Amgen Inc (AMGN)
270.90
+2.03
(+0.76%)
USD |
NASDAQ |
Mar 18, 16:00
271.87
+0.97
(+0.36%)
After-Hours: 07:58
Amgen Price: 270.90 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 270.00 | 273.58 | 269.21 | 270.90 | 3.585M |
Mar 15, 2024 | 272.09 | 275.18 | 268.17 | 268.87 | 8.796M |
Mar 14, 2024 | 276.84 | 277.23 | 270.45 | 271.54 | 2.370M |
Mar 13, 2024 | 278.18 | 278.56 | 275.21 | 275.99 | 1.641M |
Mar 12, 2024 | 276.85 | 278.15 | 274.14 | 276.54 | 1.739M |
Mar 11, 2024 | 274.51 | 278.19 | 272.99 | 275.36 | 1.851M |
Mar 08, 2024 | 272.81 | 276.56 | 272.01 | 273.75 | 2.251M |
Mar 07, 2024 | 276.30 | 276.81 | 269.58 | 272.86 | 4.066M |
Mar 06, 2024 | 275.38 | 278.97 | 274.55 | 276.59 | 2.240M |
Mar 05, 2024 | 279.62 | 279.75 | 275.02 | 276.65 | 3.064M |
Mar 04, 2024 | 283.26 | 285.89 | 277.65 | 279.39 | 2.470M |
Mar 01, 2024 | 276.50 | 281.92 | 274.88 | 280.33 | 3.773M |
Feb 29, 2024 | 278.52 | 279.82 | 273.43 | 273.83 | 5.863M |
Feb 28, 2024 | 278.99 | 280.43 | 277.09 | 277.46 | 3.027M |
Feb 27, 2024 | 279.10 | 281.22 | 277.09 | 278.49 | 3.354M |
Feb 26, 2024 | 288.28 | 289.87 | 285.42 | 286.37 | 2.449M |
Feb 23, 2024 | 286.52 | 292.24 | 286.01 | 289.18 | 2.463M |
Feb 22, 2024 | 282.48 | 285.72 | 281.30 | 285.18 | 2.993M |
Feb 21, 2024 | 284.84 | 285.78 | 280.80 | 283.46 | 1.934M |
Feb 20, 2024 | 283.85 | 285.30 | 280.55 | 283.51 | 3.402M |
Feb 16, 2024 | 287.71 | 287.71 | 283.27 | 283.70 | 3.597M |
Feb 15, 2024 | 287.88 | 290.35 | 285.60 | 289.07 | 2.902M |
Feb 14, 2024 | 289.88 | 290.87 | 287.54 | 290.07 | 2.617M |
Feb 13, 2024 | 294.61 | 295.52 | 286.89 | 290.48 | 3.610M |
Feb 12, 2024 | 289.97 | 294.60 | 288.86 | 294.43 | 3.299M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
166.70
Minimum
May 31 2019
324.56
Maximum
Feb 01 2024
235.22
Average
235.86
Median
Jun 30 2020
Price Benchmarks
Gilead Sciences Inc | 73.26 |
Johnson & Johnson | 156.76 |
Eli Lilly and Co | 762.66 |
Merck & Co Inc | 121.44 |
Vertex Pharmaceuticals Inc | 411.10 |
Price Related Metrics
PE Ratio | 21.69 |
PS Ratio | 5.168 |
PEG Ratio | 6.912 |
Price to Book Value | 23.30 |
Price to Free Cash Flow | 19.80 |
Earnings Yield | 4.61% |
Market Cap | 145.18B |
PEGY Ratio | 3.428 |
Operating PE Ratio | 18.45 |
Normalized PE Ratio | 21.69 |